Runben Biotechnology Co., Ltd. (603193)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
21. 64
+0.52
+2.4621%
¥
9B Market Cap
- P/E Ratio
0.68% Div Yield
4.32M Volume
- Eps
¥ 21.12
Previous Close Want to track 603193 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Runben Biotechnology Co., Ltd. (603193) Statistics
Valuation metrics
Market Cap 9B
Enterprise value 8.24B
Trailing P/E (ttm) 25.99
Forward P/E -
PEG ratio 3.9
Price/Sales (ttm) 5.35
Price/Book (mrq) 3.7
Enterprise Value/Revenue 5.24
Enterprise Value/EBITDA 21.79
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.24M
Average volume (90 days) 3.28M
Price summary
52-Week low 17.77
52-Week high 32.37
Beta -
50-Day moving average 19.72
200-Day moving average 22.49
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.46
Trailing annual dividend yield 0.0221%
5-Year annual dividend yield -
Payout ratio 0.3
Dividend Date 29 May 2026
Ex-Dividend Date 29 May 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.21%
Operating margin 0.23%
Operational effectiveness
Return on assets 0.13%
Return on equity 0.15%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.89
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.8
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.82
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 10.98%
Book value per share (mrq) 5.62
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
